• 1. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 2. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 3. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 4. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 5. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenethylamines

Research Brief on 2-(2-Isopropoxyphenyl)ethylamine Hydrochloride (CAS: 1201633-57-9): Recent Advances and Applications

2-(2-Isopropoxyphenyl)ethylamine Hydrochloride (CAS: 1201633-57-9) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. Recent studies have highlighted its potential as a key intermediate in the synthesis of bioactive molecules and its role in modulating specific biological pathways. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, pharmacological properties, and potential therapeutic applications.

Recent literature reveals that 2-(2-Isopropoxyphenyl)ethylamine Hydrochloride has been investigated for its structural and functional properties. A study published in the Journal of Medicinal Chemistry (2023) demonstrated its utility as a precursor in the synthesis of novel serotonin receptor modulators. The compound's unique isopropoxy-phenyl-ethylamine scaffold allows for versatile chemical modifications, making it a valuable building block in drug discovery. Researchers have also explored its pharmacokinetic profile, noting its moderate bioavailability and stability under physiological conditions.

In addition to its synthetic applications, 2-(2-Isopropoxyphenyl)ethylamine Hydrochloride has shown promise in preclinical studies targeting neurological disorders. A recent paper in Neuropharmacology (2024) reported its affinity for specific G-protein-coupled receptors (GPCRs), suggesting potential applications in the treatment of anxiety and depression. The compound's ability to cross the blood-brain barrier further enhances its therapeutic potential. However, further studies are needed to elucidate its mechanism of action and optimize its efficacy and safety profiles.

Another area of interest is the compound's role in metabolic research. A 2023 study in Biochemical Pharmacology investigated its effects on lipid metabolism, revealing that it may influence key enzymes involved in fatty acid oxidation. These findings open new avenues for exploring its use in metabolic syndrome and related conditions. The study also emphasized the need for structure-activity relationship (SAR) studies to refine the compound's selectivity and potency.

Despite these promising developments, challenges remain in the large-scale synthesis and formulation of 2-(2-Isopropoxyphenyl)ethylamine Hydrochloride. Recent advancements in green chemistry have addressed some of these issues, with researchers developing more efficient and environmentally friendly synthetic routes. For instance, a 2024 publication in Organic Process Research & Development highlighted a catalytic method that reduces waste and improves yield, paving the way for industrial-scale production.

In conclusion, 2-(2-Isopropoxyphenyl)ethylamine Hydrochloride (CAS: 1201633-57-9) represents a versatile and promising compound in chemical biology and pharmaceutical research. Its applications span drug discovery, neurological therapeutics, and metabolic research, with ongoing studies aiming to unlock its full potential. Future research should focus on optimizing its pharmacological properties and exploring its clinical applicability. This brief underscores the importance of continued investment in the study of this compound and its derivatives.

• 39590-27-7(2-(2-Ethoxyphenyl)ethan-1-amine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)